title: Reply to Sachdev et al.
authors.affiliation: Department of Internal Medicine, University of California, San Diego, La Jolla.
authors.forename: Maile Y
authors.initials: MY
authors.lastname: Karris
authors.affiliation: Department of Internal Medicine.
authors.forename: Susan E
authors.initials: SE
authors.lastname: Beekmann
authors.affiliation: Department of Internal Medicine, University of California, San Diego, La Jolla.
authors.forename: Sanjay R
authors.initials: SR
authors.lastname: Mehta
authors.affiliation: Department of Internal Medicine Department of Epidemiology, University of Iowa Carver College of Medicine, Iowa City.
authors.forename: Philip M
authors.initials: PM
authors.lastname: Polgreen
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000706:statistics & numerical data*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D065129:Pre-Exposure Prophylaxis / Q000379:methods*
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine
references.citation: Clin Infect Dis. 2014 Mar;58(5):704-12
references.pmid: 24319083